MINGHANG ZHANG – Trademark Portfolio

Entity Type: 01

MINGHANG ZHANG holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 11 (Environmental Control) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include HREEPUM and KUROUMT. The owner is based in Shantou City, Guangdon.

No. 3, Lane 13, Xinzhong Menzai Road,

Shantou City, Guangdon 515100 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

HREEPUM
HREEPUM
Registered 2021
KUROUMT
KUROUMT
Registered 2021

Trademark Classifications

MINGHANG ZHANG's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

11
Environmental Control (1 filing)

Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does MINGHANG ZHANG have?

MINGHANG ZHANG has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does MINGHANG ZHANG file in?

MINGHANG ZHANG files trademarks across 2 Nice Classification classes. The most active classes are Class 11 (Environmental Control), Class 10 (Medical Apparatus). Class 11 covers apparatus for lighting, heating, steam generating, cooking, refrigerating, drying.

What are MINGHANG ZHANG's most well-known trademarks?

MINGHANG ZHANG's registered trademark portfolio includes well-known marks such as HREEPUM and KUROUMT. These are among 2 currently registered trademarks in the portfolio.

What is MINGHANG ZHANG's trademark registration success rate?

MINGHANG ZHANG has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.